These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18461015)

  • 1. Cost and effectiveness of Chlamydia screening among male military recruits: Markov modeling of complications averted through notification of prior female partners.
    Nevin RL; Shuping EE; Frick KD; Gaydos JC; Gaydos CA
    Sex Transm Dis; 2008 Aug; 35(8):705-13. PubMed ID: 18461015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.
    Howell MR; Gaydos JC; McKee KT; Quinn TC; Gaydos CA
    Sex Transm Dis; 1999 Oct; 26(9):519-26. PubMed ID: 10534206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR; Gaydos CA; Quinn TC
    Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
    Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost effectiveness of opportunistic chlamydia screening in England.
    Adams EJ; Turner KM; Edmunds WJ
    Sex Transm Infect; 2007 Jul; 83(4):267-74; discussion 274-5. PubMed ID: 17475686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals.
    Smith KJ; Cook RL; Roberts MS
    Value Health; 2007; 10(5):358-66. PubMed ID: 17888100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic evaluation of a school-based sexually transmitted disease screening program.
    Wang LY; Burstein GR; Cohen DA
    Sex Transm Dis; 2002 Dec; 29(12):737-45. PubMed ID: 12466713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community.
    Gift TL; Lincoln T; Tuthill R; Whelan M; Briggs LP; Conklin T; Irwin KL
    Sex Transm Dis; 2006 Oct; 33(10 Suppl):S103-10. PubMed ID: 17003677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
    Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
    Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
    van Valkengoed IG; Postma MJ; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the burden of disease and costs of genital Chlamydia trachomatis infection in Canada.
    Tuite AR; Jayaraman GC; Allen VG; Fisman DN
    Sex Transm Dis; 2012 Apr; 39(4):260-7. PubMed ID: 22421691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis.
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Jager HC; Coutinho RA
    Value Health; 2001; 4(3):266-75. PubMed ID: 11705188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use age to target chlamydial screening.
    Contracept Technol Update; 1998 Aug; 19(8):104-5. PubMed ID: 12348576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN
    Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study.
    Looker KJ; Wallace LA; Turner KM
    Theor Biol Med Model; 2015 Jan; 12():2. PubMed ID: 25588390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data.
    de Vries R; van Bergen JE; de Jong-van den Berg LT; Postma MJ;
    Value Health; 2006; 9(1):1-11. PubMed ID: 16441519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial.
    Aghaizu A; Adams EJ; Turner K; Kerry S; Hay P; Simms I; Oakeshott P
    Sex Transm Infect; 2011 Jun; 87(4):312-7. PubMed ID: 21444333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?
    Chen S; Li J; van den Hoek A
    Sex Transm Dis; 2007 Apr; 34(4):230-6. PubMed ID: 17414068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-entry screening for C. trachomatis In female army recruits. Who derives the cost savings?
    Howell MR; McKee KTJr ; Gaydos JC; Quinn TC; Gaydos CA
    Am J Prev Med; 2000 Oct; 19(3):160-6. PubMed ID: 11020592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.